Ford to Produce 50,000 Ventilators in Michigan In Next 100 Days
Ford Motor Company, in collaboration with GE Healthcare, announced that it will begin producing in Michigan a third-party ventilator with the goal to produce 50,000 of the vitally needed units within 100 days and up to 30,000 a month thereafter as needed. Ford will provide its manufacturing capabilities to quickly scale production, and GE Healthcare will provide its clinical expertise and will license the current ventilator design from Airon Corp, a small, privately held company specializing in high-tech pneumatic life support products. GE Healthcare brought the Airon Corp. design to Ford’s attention as part of the companies’ efforts to scale production of ventilators quickly to help clinicians treat COVID-19 patients. The GE/Airon Model A-E ventilator uses a design that operates on air pressure without the need for electricity, addressing the needs of most COVID-19 patients. Its production can be quickly scaled to help meet growing demand in the US.
Ford will initially send a team to work with Airon to boost production in Florida, and by the week of April 20, will start production at Ford’s Rawsonville Components Plant in Ypsilanti, Mich., quickly ramping up to reach full production to help meet surging demand.
Ford expects to produce 1,500 by the end of April, 12,000 by the end of May and 50,000 by July 4 – helping the U.S. government meet its goal of producing 100,000 ventilators in 100 days.
Ford’s Rawsonville plant will produce the ventilators nearly around the clock, with 500 paid volunteer UAW-represented employees working on three shifts. Airon currently produces three Airon pNeuton Model A ventilators per day in Melbourne, Fla. At full production, Ford plans to make 7,200 Airon-licensed Model A-E ventilators per week.
The Airon-licensed Model A-E ventilator is the second Ford-GE Healthcare ventilator collaboration. Last week, Ford and GE Healthcare announced a separate effort to produce a simplified ventilator design from GE Healthcare. The combined ventilator supply will help address the increasing surge demand for ventilators around the U.S in the fight against COVID-19, each well suited to meet time, production volume and patient care requirements.
Source : Strategic Research Institute